Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Inventories, Raw Materials & Components: HK$48.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02291 Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
76 GF Score
Price HK$12.18
GF Value HK$44.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lepu Scientech Medical Technology (Shanghai) Co Inventories, Raw Materials & Components?

Lepu Scientech Medical Technology (Shanghai) Co HKSE:02291 +6.75% 76 Inventories, Raw Materials & Components is HK$48.1 Mil as of Dec. 2025. GuruFocus rates HKSE:02291 with a GF Score™ of 76/100 and a GF Value™ of HK$44.29 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Lepu Scientech Medical Technology (Shanghai) Co's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$48.1 Mil.

Lepu Scientech Medical Technology (Shanghai) Co's quarterly raw materials increased from Dec. 2024 (HK$36.1 Mil) to Jun. 2025 (HK$39.6 Mil) and increased from Jun. 2025 (HK$39.6 Mil) to Dec. 2025 (HK$48.1 Mil).

Lepu Scientech Medical Technology (Shanghai) Co's annual raw materials increased from Dec. 2023 (HK$33.3 Mil) to Dec. 2024 (HK$36.1 Mil) and increased from Dec. 2024 (HK$36.1 Mil) to Dec. 2025 (HK$48.1 Mil).

Lepu Scientech Medical Technology (Shanghai) Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lepu Scientech Medical Technology (Shanghai) Co Inventories, Raw Materials & Components Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 13.80 30.28 33.32 36.08 48.08

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.32 37.52 36.08 39.60 48.08
HKSE:02291
76GF Score
Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lepu Scientech Medical Technology (Shanghai) Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$48.1 Mil mean?
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Inventories, Raw Materials & Components of HK$48.1 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors.
Is Lepu Scientech Medical Technology (Shanghai) Co's Inventories, Raw Materials & Components too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Inventories, Raw Materials & Components is HK$48.1 Mil. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Inventories, Raw Materials & Components compare to ABT and SYK?
Lepu Scientech Medical Technology (Shanghai) Co's Inventories, Raw Materials & Components of HK$48.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. Lepu Scientech Medical Technology (Shanghai) Co's current Inventories, Raw Materials & Components is HK$48.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.29, compared to a current price of HK$12.18 — trading 72.5% below its estimated fair value. The current Inventories, Raw Materials & Components is HK$48.1 Mil. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Inventories, Raw Materials & Components is HK$48.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?

Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued. The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29. GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.

Key valuation signals for HKSE:02291:

  • Inventories, Raw Materials & Components: HK$48.1 Mil
  • GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lepu Scientech Medical Technology (Shanghai) Co Business Description

Address No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score

Get the complete analysis for HKSE:02291

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.18
Price
HK$44.29
GF Value